Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$3.53 - $5.5 $357,677 - $557,287
-101,325 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$4.99 - $6.55 $505,611 - $663,678
101,325 New
101,325 $506,000
Q2 2021

Aug 16, 2021

SELL
$6.24 - $8.22 $409,362 - $539,256
-65,603 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$6.74 - $10.95 $442,164 - $718,352
65,603 New
65,603 $452,000
Q4 2020

Feb 11, 2021

SELL
$3.75 - $10.56 $48,262 - $135,907
-12,870 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.5 - $6.2 $45,045 - $79,794
12,870 New
12,870 $45,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $306M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.